Literature DB >> 24730009

Total hip and knee replacement in a patient with arthrogryposis multiplex congenita.

Kimberly A Fisher, David A Fisher1.   

Abstract

Arthrogryposis multiplex congenita (AMC) is a complex disorder that leads to joint stiffness and deformities in 2 or more joints in afflicted children. Late manifestations of this disorder can include secondary degeneration of the abnormal joints with arthritic symptoms of pain and loss of function. There are few reports in the orthopedic literature on the use of total joint arthroplasty to improve the pain and function in patients with arthrogryposis. This case report presents one patient who underwent bilateral total hip and total knee arthroplasties for deteriorating function and pain in her hips and knees secondary to the congenital deformities created by arthrogryposis multiplex congenita. We discuss the intraoperative difficulties and techniques used to reconstruct her hips and knees, as well as the potential indications for joint arthroplasty in this challenging group of patients.

Entities:  

Mesh:

Year:  2014        PMID: 24730009

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  3 in total

1.  Characterizing Pain Among Adolescents and Young Adults With Arthrogryposis Multiplex Congenita.

Authors:  Jaclyn Megan Sions; Maureen Donohoe; Emma Haldane Beisheim-Ryan; Ryan Todd Pohlig; Tracy Michele Shank; Louise Reid Nichols
Journal:  Pediatr Phys Ther       Date:  2022-05-30       Impact factor: 1.452

2.  Bilateral total hip replacement in arthrogryposis multiplex congenita.

Authors:  David Michael Dalton; Paul Magill; Kevin James Mulhall
Journal:  BMJ Case Rep       Date:  2015-11-25

3.  Total joint replacement of the hip and knee in patients with arthrogryposis multiplex congenita: a report of six joints.

Authors:  Christoph Theil; Robert Roedl; Georg Gosheger; Burkhard Moellenbeck; Adrien Frommer; Ralf Dieckmann; Bjoern Vogt
Journal:  Arch Orthop Trauma Surg       Date:  2020-10-10       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.